Showing results (371-380 of 651) with videos related to

Sort By:
Pageof 66
Kidney International Reports|February 3, 2026
A FIDELITY Analysis on Finerenone With SGLT-2i and GLP-1RA in CKDAjay K Singh, Stefan D Anker, Bertram Pitt, et al.
Diabetes Care|January 28, 2021
Changes in Albuminuria Predict Cardiovascular and Renal Outcomes in Type 2 Diabetes: A Post Hoc Analysis of the LEADER TrialFrederik Persson, Stephen C Bain, Ofri Mosenzon, et al.
ESC Heart Failure|July 29, 2024
Coronary microvascular dysfunction and left heart filling pressures in patients with type 2 diabetesEmil Wolsk, Mikkel Jürgens, Morten Schou, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 14, 2022
Design of the COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint study (CONFIDENCE)Jennifer B Green, Amy K Mottl, George Bakris, et al.
JACC. Cardiovascular Imaging|March 10, 2015
Global longitudinal strain is not impaired in type 1 diabetes patients without albuminuria: the Thousand & 1 studyMagnus Thorsten Jensen, Peter Sogaard, Henrik Ullits Andersen, et al.
Diabetes, Obesity & Metabolism|July 3, 2023
The effects of empagliflozin on measured glomerular filtration rate and estimated extracellular and plasma volumes in patients with type 2 diabetesMikkel Jürgens, Morten Schou, Philip Hasbak, et al.
Diabetologia|October 31, 2019
Echocardiography improves prediction of major adverse cardiovascular events in a population with type 1 diabetes and without known heart disease: the Thousand & 1 StudyMagnus T Jensen, Peter Sogaard, Ida Gustafsson, et al.
Cardiovascular Diabetology|September 16, 2023
Insulin resistance, kidney outcomes and effects of the endothelin receptor antagonist atrasentan in patients with type 2 diabetes and chronic kidney diseaseJ David Smeijer, Donald E Kohan, Peter Rossing, et al.
Acta Diabetologica|August 31, 2020
Serum glycated albumin predicts all-cause mortality in dialysis patients with diabetes mellitus: meta-analysis and systematic review of a predictive biomarkerSidar Copur, Dimitrie Siriopol, Baris Afsar, et al.
Proteomics|August 15, 2013
Improving peptide relative quantification in MALDI-TOF MS for biomarker assessmentAmaya Albalat, Angelique Stalmach, Vasiliki Bitsika, et al.
Pageof 66